167 related articles for article (PubMed ID: 33046535)
1. Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma.
Ali FR; Marcos D; Chernukhin I; Woods LM; Parkinson LM; Wylie LA; Papkovskaia TD; Davies JD; Carroll JS; Philpott A
Mol Cancer Res; 2020 Dec; 18(12):1759-1766. PubMed ID: 33046535
[TBL] [Abstract][Full Text] [Related]
2. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma.
Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A
Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414
[TBL] [Abstract][Full Text] [Related]
3. The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma.
Parkinson LM; Gillen SL; Woods LM; Chaytor L; Marcos D; Ali FR; Carroll JS; Philpott A
Front Cell Dev Biol; 2022; 10():942579. PubMed ID: 36263020
[TBL] [Abstract][Full Text] [Related]
4. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
6. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells.
Cetinkaya C; Hultquist A; Su Y; Wu S; Bahram F; Påhlman S; Guzhova I; Larsson LG
Mol Cancer Ther; 2007 Oct; 6(10):2634-41. PubMed ID: 17938259
[TBL] [Abstract][Full Text] [Related]
7. PCP4/PEP19 downregulates neurite outgrowth via transcriptional regulation of Ascl1 and NeuroD1 expression in human neuroblastoma M17 cells.
Kitazono I; Hamada T; Yoshimura T; Kirishima M; Yokoyama S; Akahane T; Tanimoto A
Lab Invest; 2020 Dec; 100(12):1551-1563. PubMed ID: 32641824
[TBL] [Abstract][Full Text] [Related]
8. E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells.
Rothschild G; Zhao X; Iavarone A; Lasorella A
Mol Cell Biol; 2006 Jun; 26(11):4351-61. PubMed ID: 16705184
[TBL] [Abstract][Full Text] [Related]
9. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.
Kasim M; Benko E; Winkelmann A; Mrowka R; Staudacher JJ; Persson PB; Scholz H; Meier JC; Fähling M
J Biol Chem; 2014 Sep; 289(39):26973-26988. PubMed ID: 25124043
[TBL] [Abstract][Full Text] [Related]
10. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
11. N-myc and noncoding RNAs in neuroblastoma.
Buechner J; Einvik C
Mol Cancer Res; 2012 Oct; 10(10):1243-53. PubMed ID: 22936790
[TBL] [Abstract][Full Text] [Related]
12. The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro.
Ali FR; Cheng K; Kirwan P; Metcalfe S; Livesey FJ; Barker RA; Philpott A
Development; 2014 Jun; 141(11):2216-24. PubMed ID: 24821983
[TBL] [Abstract][Full Text] [Related]
13. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
Liu T; Tee AE; Porro A; Smith SA; Dwarte T; Liu PY; Iraci N; Sekyere E; Haber M; Norris MD; Diolaiti D; Della Valle G; Perini G; Marshall GM
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18682-7. PubMed ID: 18003922
[TBL] [Abstract][Full Text] [Related]
14. N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.
Armstrong MB; Mody RJ; Ellis DC; Hill AB; Erichsen DA; Wechsler DS
Neoplasia; 2013 Dec; 15(12):1363-70. PubMed ID: 24403858
[TBL] [Abstract][Full Text] [Related]
15. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of achaete-scute complex homolog 1 (ASCL1) in neuroblastoma cells induces up-regulation of insulin-like growth factor 2 (IGF2).
Li J; Neumann I; Volkmer I; Staege MS
Mol Biol Rep; 2011 Mar; 38(3):1515-21. PubMed ID: 20842449
[TBL] [Abstract][Full Text] [Related]
17. ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation.
Azzarelli R; McNally A; Dell'Amico C; Onorati M; Simons B; Philpott A
Sci Rep; 2022 Feb; 12(1):2341. PubMed ID: 35149717
[TBL] [Abstract][Full Text] [Related]
18. A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets.
Castro DS; Martynoga B; Parras C; Ramesh V; Pacary E; Johnston C; Drechsel D; Lebel-Potter M; Garcia LG; Hunt C; Dolle D; Bithell A; Ettwiller L; Buckley N; Guillemot F
Genes Dev; 2011 May; 25(9):930-45. PubMed ID: 21536733
[TBL] [Abstract][Full Text] [Related]
19. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
[TBL] [Abstract][Full Text] [Related]
20. Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation.
Woods LM; Ali FR; Gomez R; Chernukhin I; Marcos D; Parkinson LM; Tayoun ANA; Carroll JS; Philpott A
BMC Genomics; 2022 Apr; 23(1):255. PubMed ID: 35366798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
